FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

By AHJ Staff June 17, 2020

The U.S. Food and Drug Administration recently rescinded its emergency use authorization for hydroxychloroquine to treat COVID-19. Based on new evidence, the agency said that the potential benefits of taking hydroxychloroquine and chloroquine to treat COVID-19 did not outweigh the risks (The New York Times).

AHJ Staff

American Healthcare Journal is healthcare’s No. 1 source for the latest insights, news and analysis. An authoritative, digital-first and editorially independent publication committed to providing decision makers with unparalleled thought leadership and objective, industry-focused information to help them run their businesses in the new era of healthcare.

Newsletter
Enter your email address to
subscribe to our newsletter.

Thank you for Signing Up
Please correct the marked field(s) below.
1,true,6,Subscriber Email,2
1,false,1,First Name,2
COVID-19 Resource Center ›
Featured Articles

November 17, 2021
Sen. Daines: Access to Telehealth Beyond The COVID-19 Pandemic Is Critical for All Americans

The COVID-19 pandemic has taken a toll on all Americans. And over a year and a half later, we’re still facing challenges combating this virus and living with the ramifications of lockdowns, economic hardships, and social isolation.

Read More

July 9, 2021
Sen. Feinstein: Congress Must Address The Youth Vaping Crisis

Even before COVID-19 ravaged our country, e-cigarettes posed a serious health threat to America’s youth. As we emerge from the COVID-19 pandemic, the youth vaping crisis remains an urgency that Congress must address.

Read More

June 16, 2021
Survey: More Than 70 Percent of Medical Practices Expect Their Patient Volume in 2021 to be Higher Than 2020

Majority of remaining practices uncertain when pre-COVID levels will resume

Read More

FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

Featured Articles

Sen. Daines: Access to Telehealth Beyond The COVID-19 Pandemic Is Critical for All Americans

Sen. Feinstein: Congress Must Address The Youth Vaping Crisis

Survey: More Than 70 Percent of Medical Practices Expect Their Patient Volume in 2021 to be Higher Than 2020

Featured Articles

Sen. Feinstein: Congress Must Address The Youth Vaping Crisis

Survey: More Than 70 Percent of Medical Practices Expect Their Patient Volume in 2021 to be Higher Than 2020

To Create ‘Just’ Medicine, What Is In Your Lane?

Who Should Be Next?

FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

Related Posts